Back to search

Peptide record

TPDB42896

#6(M108-L127) Anticancer standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42896
#6(M108-L127)
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 30-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
RRRRRRRRGGMWKGFILTVVELRVPTDLTL
Physicochemical Analysis
C162H281N59O38S1
ANCQHSY
R
3695.45
12.70
10
2
11
+8
6.88
-0.673
94.00
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
5500
148.83
3
Residue Composition
number
0
A
9
R
0
N
1
D
0
C
1
E
0
Q
3
G
0
H
1
I
4
L
1
K
1
M
1
F
1
P
0
S
3
T
1
W
0
Y
3
V
Amino Acid Distribution
A: 0 R: 9 N: 0 D: 1 C: 0 E: 1 Q: 0 G: 3 H: 0 I: 1 L: 4 K: 1 M: 1 F: 1 P: 1 S: 0 T: 3 W: 1 Y: 0 V: 3
Chemical Descriptors
30
C162H281N59O38S1
3695.45
12.70
+8
6.88
-0.673
Free
L
Linear
Free
Anticancer
STAP-2 PH domain–derived peptide
Evidence Records 2 records
Evidence 1 Activity

Activity

Graph figure 1-B
Anticancer

Target

Liver Cancer
DU-145
Liver

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

Graph figure 1-B
Anticancer

Target

Breast Cancer
MCF-7
Breast

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023